Elantas Beck

Which are the latest news on Elantas Beck?

Why is Elantas Beck India Ltd falling/rising?

As of 05-Sep, Elantas Beck India Ltd's stock price is rising, currently at 12,260.50, with a notable increase of 6.54% over the past week and 26.01% over the past month, significantly outperforming the Sensex. Strong fundamentals, including a net-debt free status and a 127.99% growth in net profit, are contributing to positive investor sentiment and the stock's upward momentum.

As of 05-Sep, Elantas Beck India Ltd's stock price is rising, currently at 12,260.50, with a change of 97.1 (0.8%) upwards. The stock has shown strong performance over various periods, with a notable increase of 6.54% over the past week and 26.01% over the past month, significantly outperforming the Sensex, which has declined by 0.97% and 2.44% respectively during the same periods. Year-to-date, the stock has risen by 28.07%, while the Sensex has fallen by 10.21%.<BR><BR>Today's performance indicates that the stock has outperformed its sector by 0.78% and has been on a consecutive gain streak for the last three days, accumulating a total return of 8.93% in that timeframe. Additionally, Elantas Beck is trading above its moving averages across multiple time frames, which is a positive indicator of its price momentum.<BR><BR>Investor participation has also increased, with a delivery volume rise of 21.21% compared to the 5-day average, suggesting growing interest in the stock. The liquidity of the stock is adequate for trading, further supporting its price stability.<BR><BR>The company's strong fundamentals contribute to its rising stock price. It is net-debt free and has reported a remarkable growth in net profit of 127.99%, alongside record high net sales and profit before depreciation, interest, and taxes (PBDIT) in its latest quarterly results. The high return on equity (ROE) of 15.28% reflects efficient management, and the stock has consistently outperformed broader market indices over the long term.<BR><BR>In summary, the combination of strong recent performance, positive investor sentiment, and solid financial results are driving the rise in Elantas Beck India Ltd's stock price.

Who are in the management team of Elantas Beck?

The management team of Elantas Beck includes Suresh Talwar, Ranjal Laxmana Shenoy, Martin Babilas (Chairman), Stefan Genten, Abhijit Tikekar, Srikumar Ramakrishnan (Managing Director), Dhekne Vasant Nandkumar, Usha Rajeev, and Ravindra Kumar, who collectively oversee the company's operations and strategic direction.

The management team of Elantas Beck includes the following members:<BR><BR>1. **Suresh Talwar** - Independent Director<BR>2. **Ranjal Laxmana Shenoy** - Independent Director<BR>3. **Martin Babilas** - Chairman (Non-Executive)<BR>4. **Stefan Genten** - Alternate Director<BR>5. **Abhijit Tikekar** - Company Secretary & Compliance Officer<BR>6. **Srikumar Ramakrishnan** - Managing Director<BR>7. **Dhekne Vasant Nandkumar** - Independent Director<BR>8. **Usha Rajeev** - Independent Director<BR>9. **Ravindra Kumar** - Director<BR><BR>This team plays a crucial role in overseeing the company's operations and strategic direction.

What does Elantas Beck do?

Elantas Beck India Ltd is a small-cap manufacturer of specialty chemicals for the electrical insulation and construction industries, with recent net sales of 283 Cr and a net profit of 71 Cr as of June 2026. The company has a market cap of INR 9,159 Cr and key metrics include a P/E ratio of 52.00 and a return on equity of 17.61%.

Overview: <BR>Elantas Beck India Ltd is a manufacturer of specialty chemicals for the electrical insulation and construction industries, categorized as a small-cap company in the specialty chemicals sector.<BR><BR>History: <BR>Incorporated on March 15, 1956, Elantas Beck India Ltd was formerly known as Beck India Limited. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 283 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 71 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 9,159 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 52.00 <BR>Industry P/E: 43 <BR>Dividend Yield: 0.06% <BR>Debt-Equity: -0.66 <BR>Return on Equity: 17.61% <BR>Price to Book: 9.11<BR><BR>Contact Details: <BR>Address: 147 Mumbai-Pune Road, Pimpri Pune Maharashtra : 411018 <BR>Tel: 91-20-30610600 <BR>Email: shirish.dabir@altanachemie.com <BR>Website: http://www.elantas.com/beck-india

Who are the peers of the Elantas Beck?

Elantas Beck's peers include Anupam Rasayan, Vinati Organics, Privi Speciality, Jubilant Ingrevia, Alkyl Amines, Clean Science, Galaxy Surfactants, Balaji Amines, Archean Chemical, and Neogen Chemicals. Notably, Privi Speciality has the highest 1-year return at 56.88%, while Elantas Beck's return is 4.89%.

Peers: The peers of Elantas Beck are Anupam Rasayan, Vinati Organics, Privi Speci., Jubilant Ingrev., Alkyl Amines, Clean Science, Galaxy Surfact., Balaji Amines, Archean Chemical, and Neogen Chemicals.<BR><BR>Quality Snapshot: Excellent management risk is observed at Vinati Organics, Privi Speci., Jubilant Ingrev., Alkyl Amines, Elantas Beck, Clean Science, Galaxy Surfact., Balaji Amines, and Archean Chemical, while Average management risk is found at Anupam Rasayan and Neogen Chemicals. Below Average management risk is noted for no peers. Growth is Good for Privi Speci., while Below Average growth is seen at Anupam Rasayan, Vinati Organics, Jubilant Ingrev., Alkyl Amines, Elantas Beck, Clean Science, Galaxy Surfact., Balaji Amines, Archean Chemical, and Neogen Chemicals. Average capital structure is noted at Anupam Rasayan, while Excellent capital structure is observed at Vinati Organics, Jubilant Ingrev., Alkyl Amines, Elantas Beck, Clean Science, Galaxy Surfact., Balaji Amines, Archean Chemical, and Neogen Chemicals.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Privi Speci. at 56.88%, while Vinati Organics has the lowest at -22.38%. Elantas Beck's 1-year return of 4.89% is higher than Vinati Organics but lower than Privi Speci. Additionally, Clean Science and Archean Chemical have negative six-month returns.

How big is Elantas Beck?

As of 31st August, Elantas Beck India Ltd has a market capitalization of 9,159.00 Cr, with recent Net Sales of 937.31 Cr and a Net Profit of 177.57 Cr.

As of 31st August, Elantas Beck India Ltd has a market capitalization of 9,159.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest 4 quarters, the company reported Net Sales of 937.31 Cr and a Net Profit of 177.57 Cr.<BR><BR>The latest annual period for the balance sheet is December 2025, with Shareholder's Funds amounting to 1,008.21 Cr and Total Assets of 1,166.37 Cr.

Are Elantas Beck India Ltd latest results good or bad?

Elantas Beck India Ltd's Q1 FY27 results are strong, with a net profit of ₹70.86 crores, an 80.33% increase, and revenue growth of 27.56%. While the company shows improved margins and operational efficiency, its high valuation at 53 times trailing earnings may require investor caution.

Elantas Beck India Ltd's latest results for Q1 FY27 are quite strong and indicate a positive performance. The company reported a net profit of ₹70.86 crores, which represents an impressive 80.33% increase both quarter-on-quarter and year-on-year. Revenue also saw significant growth, rising by 27.56% from the previous quarter, reaching ₹283.39 crores, and a year-on-year increase of 34.99%.<BR><BR>Additionally, the operating margin improved to 28.83%, up 9.32 percentage points from the previous quarter, reflecting enhanced operational efficiency and pricing power. The company's return on equity stands at 14.48%, which, while slightly below its five-year average, still indicates healthy profitability.<BR><BR>Overall, the results suggest a remarkable turnaround from the previous quarter, driven by robust revenue growth and margin expansion, positioning Elantas Beck India favorably within the specialty chemicals sector. However, investors should also consider the stock's high valuation, trading at 53 times trailing earnings, which may warrant caution.

Should I buy, sell or hold Elantas Beck India Ltd?

How has been the historical performance of Elantas Beck?

Elantas Beck has shown consistent growth, with net sales increasing from 644.70 Cr in December 2022 to 748.51 Cr in December 2024, and profit after tax rising from 137.30 Cr to 139.56 Cr during the same period. Total assets grew to 1,015.34 Cr in December 2024, supported by an increase in shareholder's funds to 867.12 Cr.

Answer:<BR>The historical performance of Elantas Beck shows a consistent growth trend in net sales and profits over the years, with the latest figures for December 2024 indicating net sales of 748.51 Cr and a profit after tax of 139.56 Cr.<BR><BR>Breakdown:<BR>Elantas Beck has demonstrated a steady increase in net sales from 644.70 Cr in December 2022 to 748.51 Cr in December 2024. This growth is reflected in the operating profit, which rose from 131.42 Cr in December 2022 to 199.13 Cr in December 2024. The profit before tax remained relatively stable, with a slight decrease from 183.62 Cr in December 2023 to 183.45 Cr in December 2024, while profit after tax increased from 137.30 Cr to 139.56 Cr during the same period. The company's total assets also grew significantly, reaching 1,015.34 Cr in December 2024, up from 880.53 Cr in December 2023. This growth in assets is supported by an increase in shareholder's funds, which rose to 867.12 Cr in December 2024 from 731.99 Cr in December 2023. Cash flow from operating activities showed a decline from 133.00 Cr in December 2023 to 63.00 Cr in December 2024, but the overall net cash inflow improved to 136.00 Cr in December 2024, compared to a net outflow of 2.00 Cr in December 2023.

Is Elantas Beck technically bullish or bearish?

As of 14 October 2025, Elantas Beck's technical trend has shifted to bearish with moderate strength, driven by bearish MACD, Bollinger Bands, and moving averages, despite a mildly bullish signal from Dow Theory.

As of 14 October 2025, the technical trend for Elantas Beck has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. Key indicators driving this stance include a bearish MACD on the weekly chart, bearish Bollinger Bands on both weekly and monthly time frames, and bearish moving averages on the daily chart. The KST is also bearish on the weekly chart, while the Dow Theory shows a mildly bullish signal on the weekly but no trend on the monthly, indicating mixed signals. Overall, the bearish indicators outweigh the mildly bullish signal from Dow Theory.

Is Elantas Beck overvalued or undervalued?

As of April 7, 2020, Elantas Beck is considered very expensive and overvalued with a PE ratio of 59.66, significantly higher than peers like Godrej Industries and Deepak Nitrite, despite a strong 3-year return of 165.28% and a year-to-date decline of 19.45%.

As of 7 April 2020, Elantas Beck's valuation grade has moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently assessed as overvalued. Key ratios include a PE ratio of 59.66, an EV to EBITDA of 51.32, and a Price to Book Value of 9.33, all of which are considerably high compared to industry standards.<BR><BR>In comparison with peers, Elantas Beck's PE ratio is notably higher than Godrej Industries, which has a PE of 46.63 and is rated as attractive, and Deepak Nitrite, which has a PE of 37.97 and is also rated very expensive. The high valuation ratios suggest that Elantas Beck is trading at a premium compared to its peers, reinforcing the conclusion of overvaluation. Despite a strong 3-year return of 165.28%, the recent performance shows a year-to-date decline of 19.45%, further highlighting the disconnect between valuation and market performance.

Who are the top shareholders of the Elantas Beck?

The top shareholders of Elantas Beck are Elantas GmbH with 75.0%, followed by Nippon Life India Trustee Ltd at 7.75%, mutual funds with 11.69%, foreign institutional investors at 0.51%, and individual investors holding 9.31%.

The top shareholders of Elantas Beck include Elantas GmbH, which holds a significant 75.0% of the shares, making it the largest promoter. The highest public shareholder is Nippon Life India Trustee Ltd, representing the Nippon India Small Cap Fund, with a holding of 7.75%. Additionally, mutual funds collectively hold 11.69% through three schemes, while foreign institutional investors (FIIs) hold 0.51% across four entities. Individual investors account for 9.31% of the shares.

When is the next results date for Elantas Beck?

No Upcoming Board Meetings

Has Elantas Beck declared dividend?

Elantas Beck India Ltd has declared a 75% dividend, amounting to ₹7.5 per share, with an ex-date of April 23, 2025. While the company has shown significant long-term growth, recent short-term returns have been negative.

Elantas Beck India Ltd has declared a 75% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 75%<BR>- Amount per share: 7.5<BR>- Ex-date: April 23, 2025<BR><BR>Dividend Yield: 0.08%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -22.26%, the dividend return was 0.06%, resulting in a total return of -22.2%.<BR><BR>Over the past year, the price return was -8.88%, the dividend return was 0.07%, leading to a total return of -8.81%.<BR><BR>In the 2-year period, the price return was 62.03%, the dividend return was 0.20%, culminating in a total return of 62.23%.<BR><BR>For the 3-year period, the price return was 158.6%, the dividend return was 0.49%, resulting in a total return of 159.09%.<BR><BR>In the last 4 years, the price return was 183.26%, the dividend return was 0.60%, leading to a total return of 183.86%.<BR><BR>Over the past 5 years, the price return was 335.14%, the dividend return was 1.44%, resulting in a total return of 336.58%.<BR><BR>Overall, Elantas Beck has declared a substantial dividend, which, while contributing to total returns, has seen varied performance across different periods, with significant growth in the longer term despite recent declines in shorter periods.